The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

August 2023

Requirements and codes changed for some medical benefit drugs

What you need to know

We’ve added requirements for some medical drugs, and this article provides an overview. Health care providers also can use our comprehensive drug lists to find the updated requirements.

Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under the medical benefit. As part of this effort, we maintain comprehensive lists of requirements for our members.

In April, May and June 2023, we added requirements for some medical benefit drugs. In addition, some drugs were assigned new HCPCS codes.

Changes in requirements

For Blue Cross commercial and BCN commercial members: We added prior authorization requirements, site-of-care requirements or both as follows:

HCPCS code

Brand name

Generic name

Requirement

Prior authorization

Site of care

J3590**

Elfabrio®

pegunigalsidase alfa-iwxj

 

J3590**

Omisirge®

omidubicel-onlv

 

J3590**

Qalsody™

tofersen

 

J3590**

Vyjuvek™

beremagene geperpavec-svdt

 

For Medicare Plus Blue℠ and BCN Advantage℠ members: We added prior authorization requirements as follows:

HCPCS code

Brand name

Generic name

For dates of service on or after

J3590**

Syfovre™

pegcetacoplan injection

April 3, 2023

J9029

Adstiladrin®

nadofaragene firadenovec-vncg

May 1, 2023

J3590**

Lamzede®

velmanase alfa

May 1, 2023

Code changes

The table below shows HCPCS code changes that were effective April 1, 2023, for the medical benefit drugs we manage.

New HCPCS code

Brand name

Generic name

Q5128

Cimerli™

ranibizumab-eqrn

Q5130

Fylnetra®

pegfilgrastim-pbbk

J1411

Hemgenix®

etranacogene dezaparvovec-drlb

J1449

Rolvedon™

eflapegrastim-xnst

J1747

Spevigo®

spesolimab-sbzo

Q5127

Stimufend®

pegfilgrastim-fpgk

C9149

Tzield™

teplizumab-mzwv

Q5129

Vegzelma®

bevacizumab-adcd

J0218

Xenpozyme™

olipudase alfa-rpcp

Drug lists

For additional details, see the following drug lists:

These lists are also available on the following pages of the ereferrals.bcbsm.com website:

Additional information about these requirements

We communicated these changes previously through provider alerts that contain additional details.

You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal, availity.com.***

Additional information about Blue Cross commercial groups

For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under the medical benefit. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group list. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Note: Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust (non-Medicare) members don't participate in the standard prior authorization program.

Reminder

An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.

**May be assigned a unique code in the future.

***Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2022 American Medical Association. All rights reserved.